Gliclazide

modified-release tablet 30 mg

international nonproprietary name

Gliclazide

Ref

BM-0061

Pharmacotherapeutic group

Not established

Composition of the preparation

Not established

Pharmacological action

Not established

Indications

Not established

Special indication

Not established

Special warning

Not established

Dosage and method of administration

30 mg

Overdosage

Not established

Safety measures

Not established

Side effects

Not established

Contraindications

Not established

Interactions with other medicinal preparations

Not established

The form of release

modified-release tablet – amount in packaging : 60